Octapharma AG Overview
Pro stress-test →Octapharma is a family-owned global healthcare company headquartered in Lachen, Switzerland, founded in 1983. The company is one of the largest manufacturers of human proteins, operating in hematology, immunohematology, and critical care. Its products treat hundreds of thousands of patients annually across haematology, immunotherapy, and critical care therapeutic areas.
Strategic Profile
Pro stress-test →Octapharma produces human proteins from human plasma and human cell lines, developing coagulation factor concentrates for bleeding disorders, immunoglobulin products for immune-mediated diseases, and proteins for critically ill patients. The company operates plasma donation centers in the US and Germany plus production facilities across Austria, Germany, France, Mexico, and Sweden, handling plasma fractionation, purification, R&D, packaging, and distribution. The company maintains a robust supply chain with over 190 plasma donation centers and advanced R&D sites supporting its therapeutic portfolio.
Competitive Landscape
Pro stress-test →Octapharma is one of the largest manufacturers of human proteins globally. Key competitors in plasma-derived therapeutics include CSL Behring (CSL Limited), Grifols, and Baxter International, alongside specialized immunology and coagulation specialists. Octapharma's competitive advantages include owned plasma collection infrastructure, vertically integrated manufacturing across multiple geographies, and established product portfolio in three therapeutic areas, though competitors leverage larger parent companies' resources and broader therapeutic portfolios.
Industry Context
Octapharma AG operates in Pharmaceuticals.
Key facts
Founded: 1983 · Headquarters: Lachen, Switzerland · Employees: 11,141 · Revenue: €3.47 billion (2024) · Market cap: N/A